Evidence map›Paper›PMID 35978060›Full record

ArticleNature communications2022

Author Correction: Programmable RNA targeting by bacterial Argonaute nucleases with unconventional guide binding and cleavage specificity.

Lidiya Lisitskaya, Yeonoh Shin, Aleksei Agapov, Anna Olina, Ekaterina Kropocheva, Sergei Ryazansky, Alexei A Aravin, Daria Esyunina, Katsuhiko S Murakami, Andrey Kulbachinskiy

Abstract readPublished Erratum
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. iScience · 2023
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Lidiya Lisitskaya *Institute of Molecular Genetics, National Research Center "Kurchatov Institute", Moscow, Russia.ORCID http://orcid.org/0000-0002-5283-7983
Yeonoh Shin *Department of Biochemistry and Molecular Biology, Pennsylvania State University, University Park, PA, USA.
Aleksei Agapov *Institute of Molecular Genetics, National Research Center "Kurchatov Institute", Moscow, Russia.ORCID http://orcid.org/0000-0002-8662-8573
Anna Olina *Institute of Molecular Genetics, National Research Center "Kurchatov Institute", Moscow, Russia.ORCID http://orcid.org/0000-0003-1844-2109
Ekaterina KropochevaInstitute of Molecular Genetics, National Research Center "Kurchatov Institute", Moscow, Russia.
Sergei RyazanskyInstitute of Molecular Genetics, National Research Center "Kurchatov Institute", Moscow, Russia.ORCID http://orcid.org/0000-0002-3171-2997
Alexei A AravinDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA.ORCID http://orcid.org/0000-0002-6956-8257
Daria EsyuninaInstitute of Molecular Genetics, National Research Center "Kurchatov Institute", Moscow, Russia.
Katsuhiko S MurakamiDepartment of Biochemistry and Molecular Biology, Pennsylvania State University, University Park, PA, USA. kum14@psu.edu.ORCID http://orcid.org/0000-0003-2244-0501
Andrey KulbachinskiyInstitute of Molecular Genetics, National Research Center "Kurchatov Institute", Moscow, Russia. avkulb@yandex.ru.ORCID http://orcid.org/0000-0002-2292-6424

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35978060
PMCPMC9385736

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.